| (210) | Number of the EPO application | 17753704 |
| (220) | Filing date of the EPO application | 2017.02.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2021, 2021.12.01 |
| (110) | EPO patent number | 3417294 |
| (21) | Number of the application | e 2019 0022 |
| (71) | Name(s) of applicant(s), code of the country | Astrazeneca AB, SE;
The United States of America, as Represented
By the Secretery, Department of Health and
Human Services, US; |
| (72) | Name(s) of inventor(s), code of the country | BARRY Simon, GB;
KENDREW Jane, GB;
HO Tony, US;
WEDGE Stephen Robert, GB;
IVYSUSAN Percy, US;
KOHN Elise, US;
LEE Jung-Min, US; |
| (73) | Name(s) of owner(s), code of the country | ASTRAZENECA AB, SE;
The United States of America, as Represented
By the Secretary, Department of Health and
Human Services, US; |
| (54) | Title of the invention | METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); G01N 33/574 (2006.01.01); A61K 38/00 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/502 (2006.01.01); A61K 31/506 (2006.01.01); A61K 45/06 (2006.01.01); A61K 48/00 (2006.01.01); A61P 9/10 (2006.01.01); A61P 43/00 (2006.01.01); A61K 39/395 (2006.01.01) |
| (19) | Country | SE |
| (41) | Date of publication of the application | 2019.02.28 |
| (30) | Priority | 201662295421 P, 2016.02.15, US |
| (86) | International application | PCT/US2017/017804, 2017.02.14 |
| (87) | International publication | WO 2017/142871, 2017.08.24 |